Analysis of the cell kinetics of cancer cells in situ (for example, by Ki-67 antigen expression or mitotic counts) has been increasingly used to evaluate prognosis and/or biological behavior of various human malignancies[12]. This evidence concerns the gene MKI67 and cancer.